During the past decade, Jobst Vascular Institute conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 15 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jobst Vascular Institute" #1 sponsor was "Avinger, Inc." with 3 trials, followed by "C. R. Bard" with 3 trials sponsored, "Medtronic Cardiovascular" with 2 trials sponsored, "Otsuka America Pharmaceutical" with 2 trials sponsored and "Spectranetics Corporation" with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jobst Vascular Institute" #1 collaborator was "Massachusetts General Hospital" with 2 trials as a collaborator, "Ontario Clinical Oncology Group (OCOG)" with 2 trials as a collaborator, "AXIOM Real Time Metrics" with 1 trials as a collaborator, "BSN Medical Inc" with 1 trials as a collaborator and "Boston Scientific Corporation" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Jobst Vascular Institute" are "Peripheral Arterial Disease" (7 trials), "Peripheral Vascular Disease" (4 trials), "Arterial Occlusive Diseases" (3 trials), "Deep Vein Thrombosis" (3 trials) and "Peripheral Artery Disease" (3 trials). Many other conditions were trialed in "Jobst Vascular Institute" in a lesser frequency.

Most popular intervention types in "Jobst Vascular Institute" are "Device" (22 trials), "Drug" (7 trials), "Biological" (4 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Dual Action Pneumatic Compression Device" (2 trials), "Ixmyelocel-T" (2 trials), "Placebo" (2 trials), "Pletal" (2 trials) and "3M™ Coban™ Custom Fit Compression System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jobst Vascular Institute" are 37 trials for "All" genders.

Currently, there are NaN active trials in "Jobst Vascular Institute". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Jobst Vascular Institute, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Jobst Vascular Institute, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 21 trials that are defined as “Not Applicable".